- Home
- ATOS vs KRSA Comparison
ATOS vs KRSA Comparison
Compare ATOS & KRSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$2.27
N/A
Current Price
$31.00
Company Overview
Basic Information| Metric | ATOS | KRSA |
|---|---|---|
| Founded | 2009 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 23.4M |
| IPO Year | 2010 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ATOS | KRSA |
|---|---|---|
| Price | $2.27 | $31.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $18.67 | ★ $35.33 |
| AVG Volume (30 Days) | 47.2K | ★ 81.6K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.26 |
| EPS | N/A | ★ N/A |
| Revenue | $1,758.00 | ★ $2,074,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.70 |
| 52 Week Low | $0.53 | $29.03 |
| 52 Week High | $7.56 | $37.27 |
Technical Indicators
Market Signals| Indicator | ATOS | KRSA |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 47.10 |
| Support Level | $2.05 | $29.03 |
| Resistance Level | $2.60 | $37.27 |
| Average True Range (ATR) | 0.15 | 4.26 |
| MACD | -0.03 | -0.16 |
| Stochastic Oscillator | 39.17 | 36.07 |
Price Performance
Historical Comparison ATOS
KRSA
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.